Interleukin Genetics Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Interleukin Genetics Inc.
Deals Shaping the Medical Industry, September 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2016.
Execs On The Move, September 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Medtech Execs On The Move, April 2016
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
FDA Warns DTC Genetic Test Firms
The warning letters are the first FDA sent since it carved out a de novo risk category
for DTC carrier screening tests, clearing the path for 23andMe Inc. to relaunch its Personal Genome Service in October.
Company Information
- Industry
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice